Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $69.61 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark Bradshaw Ph.D.

Former Vice President of Biometrics and Information - Technology Icon Clinical Research, Inc., ICON Public Limited Company
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 3 different industries.

See Board Relationships
61--

Background*

Dr. Mark Bradshaw, PhD serves as Managing Director of GCP-MB, LLC. Dr. Bradshaw served as Vice President of Biometrics and Information at Technology Icon Clinical Research, Inc. of ICON plc. Dr. Bradshaw began his pharmaceutical development career at Glaxo managing statisticians, SAS programmers and data managers in drug development. He later managed the same functional areas for Syntex and Fidia Pharmaceuticals, adding IT responsibilities as well. Dr. Bradshaw also ...

Read Full Background

Corporate Headquarters*

South County Business Park
Dublin, Co. Dublin 18

Ireland

Phone: 353 1 291 2000
Fax: 353 1 291 2700

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1979
Johns Hopkins University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICLR:US $69.61 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Josef H. von Rickenbach Founder, Chairman and Chief Executive Officer
PAREXEL International Corporation
$883.3K
James C. Foster J.D.Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Charles River Laboratories International, Inc.
$1.1M
Ge Li Ph.D.Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee
WuXi PharmaTech (Cayman) Inc.
--
Miroslav Reljanovic M.D.Founder, Owner, Chief Executive Officer and Director
Ergomed Plc
38.0K GBP
D. Jamie Macdonald Chief Executive Officer and Director
INC Research Holdings, Inc.
$407.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICON PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.